Cargando…

Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments

Diabetic foot ulcers (DFUs) are very important diabetes-related lesions that can lead to serious physical consequences like amputations of limbs and equally severe social, psychological, and economic outcomes. It is reported that up to 25% of patients with diabetes develop a DFU in their lifetime, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez-Acuña, Jesus Manuel, Cardenas-Cadena, Sergio A, Marquez-Salas, Pedro A, Garza-Veloz, Idalia, Perez-Favila, Aurelio, Cid-Baez, Miguel A, Flores-Morales, Virginia, Martinez-Fierro, Margarita L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963879/
https://www.ncbi.nlm.nih.gov/pubmed/31652990
http://dx.doi.org/10.3390/antibiotics8040193
_version_ 1783488383514836992
author Ramirez-Acuña, Jesus Manuel
Cardenas-Cadena, Sergio A
Marquez-Salas, Pedro A
Garza-Veloz, Idalia
Perez-Favila, Aurelio
Cid-Baez, Miguel A
Flores-Morales, Virginia
Martinez-Fierro, Margarita L
author_facet Ramirez-Acuña, Jesus Manuel
Cardenas-Cadena, Sergio A
Marquez-Salas, Pedro A
Garza-Veloz, Idalia
Perez-Favila, Aurelio
Cid-Baez, Miguel A
Flores-Morales, Virginia
Martinez-Fierro, Margarita L
author_sort Ramirez-Acuña, Jesus Manuel
collection PubMed
description Diabetic foot ulcers (DFUs) are very important diabetes-related lesions that can lead to serious physical consequences like amputations of limbs and equally severe social, psychological, and economic outcomes. It is reported that up to 25% of patients with diabetes develop a DFU in their lifetime, and more than half of them become infected. Therefore, it is essential to manage infection and ulcer recovery to prevent negatives outcomes. The available information plays a significant role in keeping both physicians and patients aware of the emerging therapies against DFUs. The purpose of this review is to compile the currently available approaches in the managing and treatment of DFUs, including molecular and regenerative medicine, antimicrobial and energy-based therapies, and the use of plant extracts, antimicrobial peptides, growth factors, ozone, devices, and nano-medicine, to offer an overview of the assessment of this condition.
format Online
Article
Text
id pubmed-6963879
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69638792020-01-27 Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments Ramirez-Acuña, Jesus Manuel Cardenas-Cadena, Sergio A Marquez-Salas, Pedro A Garza-Veloz, Idalia Perez-Favila, Aurelio Cid-Baez, Miguel A Flores-Morales, Virginia Martinez-Fierro, Margarita L Antibiotics (Basel) Review Diabetic foot ulcers (DFUs) are very important diabetes-related lesions that can lead to serious physical consequences like amputations of limbs and equally severe social, psychological, and economic outcomes. It is reported that up to 25% of patients with diabetes develop a DFU in their lifetime, and more than half of them become infected. Therefore, it is essential to manage infection and ulcer recovery to prevent negatives outcomes. The available information plays a significant role in keeping both physicians and patients aware of the emerging therapies against DFUs. The purpose of this review is to compile the currently available approaches in the managing and treatment of DFUs, including molecular and regenerative medicine, antimicrobial and energy-based therapies, and the use of plant extracts, antimicrobial peptides, growth factors, ozone, devices, and nano-medicine, to offer an overview of the assessment of this condition. MDPI 2019-10-24 /pmc/articles/PMC6963879/ /pubmed/31652990 http://dx.doi.org/10.3390/antibiotics8040193 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ramirez-Acuña, Jesus Manuel
Cardenas-Cadena, Sergio A
Marquez-Salas, Pedro A
Garza-Veloz, Idalia
Perez-Favila, Aurelio
Cid-Baez, Miguel A
Flores-Morales, Virginia
Martinez-Fierro, Margarita L
Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments
title Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments
title_full Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments
title_fullStr Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments
title_full_unstemmed Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments
title_short Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments
title_sort diabetic foot ulcers: current advances in antimicrobial therapies and emerging treatments
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963879/
https://www.ncbi.nlm.nih.gov/pubmed/31652990
http://dx.doi.org/10.3390/antibiotics8040193
work_keys_str_mv AT ramirezacunajesusmanuel diabeticfootulcerscurrentadvancesinantimicrobialtherapiesandemergingtreatments
AT cardenascadenasergioa diabeticfootulcerscurrentadvancesinantimicrobialtherapiesandemergingtreatments
AT marquezsalaspedroa diabeticfootulcerscurrentadvancesinantimicrobialtherapiesandemergingtreatments
AT garzavelozidalia diabeticfootulcerscurrentadvancesinantimicrobialtherapiesandemergingtreatments
AT perezfavilaaurelio diabeticfootulcerscurrentadvancesinantimicrobialtherapiesandemergingtreatments
AT cidbaezmiguela diabeticfootulcerscurrentadvancesinantimicrobialtherapiesandemergingtreatments
AT floresmoralesvirginia diabeticfootulcerscurrentadvancesinantimicrobialtherapiesandemergingtreatments
AT martinezfierromargarital diabeticfootulcerscurrentadvancesinantimicrobialtherapiesandemergingtreatments